National Health Investors (NYSE:NHI) Updates FY 2022 Earnings Guidance

National Health Investors (NYSE:NHIGet Rating) updated its FY 2022 earnings guidance on Monday. The company provided earnings per share guidance of $4.320-$4.420 for the period. The company issued revenue guidance of -.

Several equities research analysts have recently issued reports on the company. Zacks Investment Research lowered National Health Investors from a hold rating to a sell rating in a research report on Tuesday, April 19th. BMO Capital Markets decreased their target price on National Health Investors from $63.00 to $61.00 and set an outperform rating for the company in a research report on Tuesday, April 19th. Credit Suisse Group assumed coverage on National Health Investors in a research report on Tuesday, February 1st. They set an underperform rating and a $51.00 target price for the company. Finally, StockNews.com assumed coverage on National Health Investors in a research report on Thursday, March 31st. They set a hold rating for the company. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, National Health Investors currently has a consensus rating of Hold and a consensus price target of $62.00.

Shares of NYSE NHI opened at $54.79 on Monday. National Health Investors has a 52 week low of $50.88 and a 52 week high of $74.75. The business has a 50-day simple moving average of $56.24 and a two-hundred day simple moving average of $56.07. The company has a quick ratio of 18.70, a current ratio of 18.70 and a debt-to-equity ratio of 0.82. The company has a market cap of $2.51 billion, a P/E ratio of 22.45 and a beta of 0.94.

National Health Investors (NYSE:NHIGet Rating) last issued its earnings results on Tuesday, February 22nd. The real estate investment trust reported $0.14 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.91). National Health Investors had a return on equity of 7.23% and a net margin of 37.43%. The company had revenue of $69.67 million during the quarter, compared to the consensus estimate of $67.14 million. During the same quarter in the prior year, the business earned $1.37 EPS. The firm’s revenue for the quarter was down 14.2% compared to the same quarter last year. Equities research analysts anticipate that National Health Investors will post 4.19 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, May 6th. Shareholders of record on Thursday, March 31st will be paid a $0.90 dividend. The ex-dividend date of this dividend is Wednesday, March 30th. This represents a $3.60 annualized dividend and a yield of 6.57%. National Health Investors’s dividend payout ratio is currently 147.54%.

Several institutional investors and hedge funds have recently modified their holdings of NHI. Penserra Capital Management LLC boosted its position in shares of National Health Investors by 191.1% during the 4th quarter. Penserra Capital Management LLC now owns 4,105 shares of the real estate investment trust’s stock valued at $235,000 after acquiring an additional 2,695 shares during the last quarter. Benchmark Investment Advisors LLC bought a new stake in shares of National Health Investors during the 4th quarter valued at about $287,000. MML Investors Services LLC boosted its position in shares of National Health Investors by 8.7% during the 4th quarter. MML Investors Services LLC now owns 5,336 shares of the real estate investment trust’s stock valued at $307,000 after acquiring an additional 427 shares during the last quarter. LPL Financial LLC boosted its position in shares of National Health Investors by 23.9% during the 4th quarter. LPL Financial LLC now owns 8,242 shares of the real estate investment trust’s stock valued at $474,000 after acquiring an additional 1,589 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC boosted its position in shares of National Health Investors by 24.3% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 9,326 shares of the real estate investment trust’s stock valued at $536,000 after acquiring an additional 1,826 shares during the last quarter. Hedge funds and other institutional investors own 63.34% of the company’s stock.

National Health Investors Company Profile (Get Rating)

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Read More

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.